Comments

Cytokinetics Stock Price, Quotes and Forecasts

Q: What sector and industry does Cytokinetics (CYTK) operate in?

Cytokinetics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

CYTKNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Q4 2024 Earnings were released on Thu Feb 27th, after the market close

The most recent conference call was at 16:30 PM, 7 days ago Click to view past webcast

Cytokinetics (CYTK) Forecast

News Earnings Cytokinetics (CYTK) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Cytokinetics Stock Price, Quotes and Forecasts | NASDAQ:CYTK | Benzinga

Explore Cytokinetics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CYTK.

Open	$43.27
Close	-
Volume / Avg.	52.04K / 1.46M
Day Range	$42.23 - $43.85
52 Wk Range	40.53 - 75.71
Market Cap	$5.12B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	44
Short Interest	19.38%
Days to Cover	6.83

Recent News

MGM Resorts To Rally Around 75%? Here Are 10 Top Analyst Forecasts For Thursday

Avi Kapoor

This AstraZeneca Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday

Avi Kapoor

Cytokinetics Heart Drug's Future Sparks Optimism Despite M&A Hurdles and Royalty Deal Concerns: Analyst

Cytokinetics receives a Buy rating from Stifel, with a promising outlook for aficamten in the $3 billion U.S. oHCM market, despite investor concerns over M&A and deals.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Dec 24

Jan

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$43.27
Close	-
Volume / Avg.	52.04K / 1.46M
Day Range	$42.23 - $43.85
52 Wk Range	40.53 - 75.71
Market Cap	$5.12B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	44
Short Interest	19.38%
Days to Cover	6.83

About Cytokinetics Inc

Sector

Health Care

Industry

Biotechnology

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and co...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Cytokinetics (CYTK) stock?

You can purchase shares of Cytokinetics (NASDAQ:CYTK) through any online brokerage.

View our list of the best stock brokerages

Who are Cytokinetics (CYTK) competitors?

Other companies in Cytokinetics’s space includes: Legend Biotech (NASDAQ:LEGN), Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA), Ionis Pharmaceuticals (NASDAQ:IONS) and Roivant Sciences (NASDAQ:ROIV).

What is the forecast, or price target, for Cytokinetics (CYTK) stock?

Cytokinetics has a consensus price target of $79.74.

What is the current price for Cytokinetics (CYTK)?

The stock price for Cytokinetics (NASDAQ: CYTK) is $43.71 last updated March 6, 2025 at 9:40 AM EST.

Does Cytokinetics (CYTK) pay a dividend?

There are no upcoming dividends for Cytokinetics.

When is Cytokinetics (NASDAQ:CYTK) reporting earnings?

Cytokinetics’s Q1 earnings are confirmed for Wednesday, May 7, 2025.

Is Cytokinetics (CYTK) going to split?

There is no upcoming split for Cytokinetics.

What sector and industry does Cytokinetics (CYTK) operate in?

Cytokinetics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.